New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
04:55 EDTBAX, BAX, BAX, BAX, NVDQ, NVDQ, NVDQ, NVDQ, RTIX, RTIX, RTIX, RTIX, SYK, SYK, SYK, SYK, TFX, TFX, TFX, TFX, GIVN, GIVN, GIVN, GIVN, EW, EW, EW, EW, ETRM, ETRM, ETRM, ETRM, ECIA, ECIA, ECIA, ECIA, COV, COV, COV, COV, CNMD, CNMD, CNMD, CNMD, CFN, CFN, CFN, CFN, CADX, CADX, CADX, CADX, BSX, BSX, BSX, BSX, NPSP, NPSP, NPSP, NPSPSociety of American Gastrointestinal & Endoscopic Surgeons holds annual meeting
2014 Annual Meeting of SAGES is being held in Salt Lake City, Utah on April 2-5.
News For BAX;BSX;CADX;CFN;CNMD;COV;ECIA;ETRM;EW;GIVN;TFX;SYK;RTIX;NVDQ;NPSP From The Last 14 Days
Check below for free stories on BAX;BSX;CADX;CFN;CNMD;COV;ECIA;ETRM;EW;GIVN;TFX;SYK;RTIX;NVDQ;NPSP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 9, 2014
15:13 EDTNPSPNPS Pharmaceuticals September volatility elevated into PDUFA
Subscribe for More Information
08:17 EDTNPSPNPS Pharmaceuticals likely volatile on briefing docs, says FBR Capital
Subscribe for More Information
06:42 EDTCOVLew expects to make decision on combating inversion deals soon, NY Times reports
Subscribe for More Information
September 8, 2014
14:37 EDTNPSPNPS Pharmaceuticals September volatility elevated into PDUFA
Subscribe for More Information
11:05 EDTCOV, NPSPOptions with increasing implied volatility
Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL
08:12 EDTCNMDCONMED urges holders to vote the GOLD proxy card
Subscribe for More Information
07:26 EDTBSXMorgan Stanley to hold a conference
Subscribe for More Information
07:04 EDTBSXBoston Scientific sell-off overdone, says RBC Capital
RBC Capital said the sell-off in Boston Scientific is overdone and that upcoming catalysts will reverse sentiment. The firm would be aggressive buyers ahead of the October 8 FDA Watchman panel and the release of pivotal Synergy data on November 19 AHA meeting. Shares are Outperform rated with a $15 price target.
07:03 EDTTFXTeleflex announces restated indications for ARROW EZ-IO use
Teleflex announced FDA 510 clearance for restated Indications for Use of the Arrow EZ-IO Vascular Access System. The EZ-IO Vascular Access System is now indicated to include the distal femur for pediatric patients.
05:47 EDTBAXBaxter price target raised to $96 from $85 at Piper Jaffray
Subscribe for More Information
September 5, 2014
11:47 EDTCOV, NPSPOptions with increasing implied volatility
Subscribe for More Information
10:32 EDTNPSPNPS Pharmaceuticals September volatility increases into PDUFA
Subscribe for More Information
09:03 EDTTFXTeleflex announces publication of ARROW PICC study
Subscribe for More Information
September 4, 2014
10:45 EDTNPSPNPS drops after Feuerstein tweets about interview offer
Subscribe for More Information
10:06 EDTNPSPNPS Pharmaceuticals September volatility elevated into PDUFA
NPS Pharmaceuticals September call option implied volatility is at 96, October is at 71, November is at 68; compared to its 26-week average of 64 according to Track Data, suggesting large near term price movement into PDUFA for Natpara on September 12.
07:17 EDTCFNCareFusion management to meet with Deutsche Bank
Subscribe for More Information
September 3, 2014
09:03 EDTEWNovation enters heart valve agreement with Edwards Lifesciences
Novation and Edwards Lifesciences announced they have entered into a three-year, sole-source strategic relationship that provides the world's market leading heart valve therapies to the more than 100,000 members and affiliates of VHA, UHC, Children's Hospital Association and Provista. The new agreement with Edwards for its heart valve product portfolio enables Novation to enter the heart valve category for the first time, and expands on the previous relationship between the companies for critical care technologies.
07:05 EDTETRMEnteroMedics' ReCharge pivotal trial obesity results published by AMA Journal
Subscribe for More Information
September 2, 2014
08:18 EDTCNMDCONMED urges holders to vote the GOLD proxy card
CONMED issued an open letter to its shareholders in connection with the company's September 10 Annual Meeting of Shareholders. CONMED's board unanimously recommends that shareholders follow the recommendations of leading proxy advisory firms Institutional Shareholder Services and Egan-Jones Proxy Services by voting "FOR" ALL of CONMED's eight director nominees as well as supporting the other proposals contained in the definitive proxy materials.
08:07 EDTBSXBoston Scientific closed agreement to acquire Interventional business of Bayer
Boston Scientific (BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer (BAYRY). The addition of the Bayer Interventional strong commercial organization and innovative technologies supports the Boston Scientific strategy to provide a comprehensive portfolio of solutions to treat peripheral vascular disease. The transaction includes the leading AngioJet Thrombectomy System and the Fetch 2 Aspiration Catheter, which are used in endovascular procedures to remove blood clots from blocked arteries and veins, and the JetStream Atherectomy System, used in an innovative and fast-growing therapy to remove plaque and thrombi from diseased arteries.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use